Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Receivables - Net: 2020-2021

  • Candel Therapeutics' Receivables - Net rose 72.44% to $1.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.1 million, marking a year-over-year increase of 72.44%. This contributed to the annual value of $1.1 million for FY2021, which is 72.44% up from last year.
  • Latest data reveals that Candel Therapeutics reported Receivables - Net of $1.1 million as of Q4 2021, which was up 463.35% from $191,000 recorded in Q1 2021.
  • In the past 5 years, Candel Therapeutics' Receivables - Net registered a high of $1.1 million during Q4 2021, and its lowest value of $191,000 during Q1 2021.
  • Over the past 2 years, Candel Therapeutics' median Receivables - Net value was $624,000 (recorded in 2020), while the average stood at $630,333.
  • Data for Candel Therapeutics' Receivables - Net shows a peak YoY surged of 72.44% (in 2021) over the last 5 years.
  • Candel Therapeutics' Receivables - Net (Quarterly) stood at $624,000 in 2020, then skyrocketed by 72.44% to $1.1 million in 2021.
  • Its Receivables - Net stands at $1.1 million for Q4 2021, versus $191,000 for Q1 2021 and $624,000 for Q4 2020.